Nabil M, Megahed F
J Fluoresc. 2023; 34(6):2467-2484.
PMID: 37878236
PMC: 11604693.
DOI: 10.1007/s10895-023-03472-0.
Razlansari M, Jafarinejad S, Rahdar A, Shirvaliloo M, Arshad R, Fathi-Karkan S
Mol Cell Biochem. 2022; 478(7):1573-1598.
PMID: 36434145
DOI: 10.1007/s11010-022-04614-x.
Huang F, Chen M, Zhou Z, Duan R, Xia F, Willner I
Nat Commun. 2021; 12(1):2364.
PMID: 33888708
PMC: 8062675.
DOI: 10.1038/s41467-021-22645-8.
Allam M, Cai S, Coskun A
NPJ Precis Oncol. 2020; 4:11.
PMID: 32377572
PMC: 7195402.
DOI: 10.1038/s41698-020-0114-1.
van den Kieboom C, van der Beek S, Meszaros T, Gyurcsanyi R, Ferwerda G, de Jonge M
Trends Analyt Chem. 2020; 74:58-67.
PMID: 32287539
PMC: 7112930.
DOI: 10.1016/j.trac.2015.05.012.
Nucleic Acid Aptamers for Molecular Therapy of Epilepsy and Blood-Brain Barrier Damages.
Zamay T, Zamay G, Shnayder N, Dmitrenko D, Zamay S, Yushchenko V
Mol Ther Nucleic Acids. 2019; 19:157-167.
PMID: 31837605
PMC: 6920299.
DOI: 10.1016/j.omtn.2019.10.042.
Aptamers as Diagnostic Tools in Cancer.
Ruiz Ciancio D, Vargas M, Thiel W, Bruno M, Giangrande P, Mestre M
Pharmaceuticals (Basel). 2018; 11(3).
PMID: 30208607
PMC: 6160954.
DOI: 10.3390/ph11030086.
Aptamer-mediated selective delivery of a cytotoxic cationic NHC-Au(i) complex to cancer cells.
Niu W, Teng I, Chen X, Tan W, Veige A
Dalton Trans. 2017; 47(1):120-126.
PMID: 29192701
PMC: 5736135.
DOI: 10.1039/c7dt02616a.
Label-Free Biochips for Accurate Detection of Prostate Cancer in the Clinic: Dual Biomarkers and Circulating Tumor Cells.
Pan L, Pang S, Fang P, Chuang C, Yang H
Theranostics. 2017; 7(17):4289-4300.
PMID: 29158826
PMC: 5695013.
DOI: 10.7150/thno.21092.
Engineering Quantum Dots with Different Emission Wavelengths and Specific Fluorescence Lifetimes for Spectrally and Temporally Multiplexed Imaging of Cells.
Zhang B, Yang C, Gao Y, Wang Y, Bu C, Hu S
Nanotheranostics. 2017; 1(1):131-140.
PMID: 29071182
PMC: 5646722.
DOI: 10.7150/ntno.18989.
Quantum Dots as Multifunctional Materials for Tumor Imaging and Therapy.
Liu L, Miao Q, Liang G
Materials (Basel). 2017; 6(2):483-499.
PMID: 28809320
PMC: 5452096.
DOI: 10.3390/ma6020483.
Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy.
Chen M, Yu Y, Jiang F, Zhou J, Li Y, Liang C
Int J Mol Sci. 2016; 17(12).
PMID: 27973403
PMC: 5187879.
DOI: 10.3390/ijms17122079.
In vitro study of novel gadolinium-loaded liposomes guided by GBI-10 aptamer for promising tumor targeting and tumor diagnosis by magnetic resonance imaging.
Gu M, Li K, Zhang L, Wang H, Liu L, Zheng Z
Int J Nanomedicine. 2015; 10:5187-204.
PMID: 26316749
PMC: 4544817.
DOI: 10.2147/IJN.S84351.
Aptamer technology for tracking cells' status & function.
Wiraja C, Yeo D, Lio D, Labanieh L, Lu M, Zhao W
Mol Cell Ther. 2015; 2:33.
PMID: 26056599
PMC: 4452066.
Impacts of quantum dots in molecular detection and bioimaging of cancer.
Mashinchian O, Johari-Ahar M, Ghaemi B, Rashidi M, Barar J, Omidi Y
Bioimpacts. 2014; 4(3):149-66.
PMID: 25337468
PMC: 4204040.
DOI: 10.15171/bi.2014.008.
Clinical applications of nucleic acid aptamers in cancer.
Pei X, Zhang J, Liu J
Mol Clin Oncol. 2014; 2(3):341-348.
PMID: 24772298
PMC: 3999129.
DOI: 10.3892/mco.2014.255.
Aptamer-targeted DNA nanostructures for therapeutic delivery.
Charoenphol P, Bermudez H
Mol Pharm. 2014; 11(5):1721-5.
PMID: 24739136
PMC: 4018137.
DOI: 10.1021/mp500047b.
Aptamers as theranostic agents: modifications, serum stability and functionalisation.
Shigdar S, Macdonald J, OConnor M, Wang T, Xiang D, Al Shamaileh H
Sensors (Basel). 2013; 13(10):13624-37.
PMID: 24152925
PMC: 3859083.
DOI: 10.3390/s131013624.
Nanoparticles and their applications in cell and molecular biology.
Wang E, Wang A
Integr Biol (Camb). 2013; 6(1):9-26.
PMID: 24104563
PMC: 3865110.
DOI: 10.1039/c3ib40165k.
Aptamers from cell-based selection for bioanalytical applications.
Tan W, Donovan M, Jiang J
Chem Rev. 2013; 113(4):2842-62.
PMID: 23509854
PMC: 5519293.
DOI: 10.1021/cr300468w.
